Effects of frequent hemodialysis on measures of CKD mineral and bone disorder

Journal of the American Society of Nephrology

Volumn 23, Issue 4, 2012, Pages 727-738

  Daugirdas, John T ^a   Chertow, Glenn M ^b   Larive, Brett ^l   Pierratos, Andreas ^d   Greene, Tom ^e   Ayus, Juan Carlos ^f   Kendrick, Cynthia A ^c   James, Sam H ^g   Miller, Brent W ^h   Schulman, Gerald ⁱ   Salusky, Isidro B ^j   Kliger, Alan S ^k  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF UTAH   (United States)

^f Renal Consultants of Houston   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k YALE UNIVERSITY   (United States)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSATE; FEMALE; FOLLOW UP; HEMODIALYSIS; HOME DIALYSIS; HUMAN; HYPOPHOSPHATEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NOCTURNAL HOME HEMODIALYSIS; PRIORITY JOURNAL;

EID: 84859872930     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011070688     Document Type: Article

References (22)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
2. Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 333: 166-174, 1995
3. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar- Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008
4. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R: Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4: 1089-1096, 2009
5. Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of ChronicKidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009
6. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S: KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis 55: 773-799, 2010
7. Moe SM, Chertow GM: The case against calciumbased phosphate binders. Clin J AmSoc Nephrol 1: 697-703, 2006
8. Jamal SA, Fitchett D, Lok CE, Mendelssohn DC, Tsuyuki RT: The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: A meta-analysis. Nephrol Dial Transplant 24: 3168-3174, 2009
9. Manns B, Klarenbach S, Lee H, Culleton B, Shrive F, Tonelli M: Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant 22: 2867-2878, 2007 (Pubitemid 350093448)
10. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998 (Pubitemid 28316904)
11. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16: 2778-2788, 2005
12. Walsh M, Manns BJ, Klarenbach S, Tonelli M, Hemmelgarn B, Culleton B: The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodial Int 14: 174-181, 2010
13. Kaysen GA, Greene T, Sanz-Berney GA, Mehta RL, Lindsay R, Depner TA, Hall YN, Daugirdas JT, Chertow GM, and the Frequent Hemodialysis Network Trial Group: The effect of frequent hemodialysis on nutrition and body composition. Kidney Int 2012, in press
14. Daugirdas JT, Finn WF, Emmett M, Chertow GM, and the Frequent Hemodialysis Network Trial Group: The phosphate binder equivalent dose. Semin Dial 24: 41-49, 2011
15. Fujimoto N, Tokuyama K, Takishita S, Iseki K: Difference in serum phosphate level by the timing of blood test in chronic dialysis patients [Abstract]. J Am Soc Nephrol 14: 361A, 2004
16. Shimazaki M: Difference in hemoglobin concentration by timing of blood sampling in hemodialysis patients. Dial Transplant 38: 350-353, 2009
17. Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C: Calcium and phosphate balance with quotidian hemodialysis. AmJ Kidney Dis 42[Suppl]: 24-29, 2003
18. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS, and the Frequent Hemodialysis Network Trial Group: Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 71: 349-359, 2007
19. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS, and the Frequent Hemodialysis Network Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
20. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, and the Frequent Hemodialysis Network (FHN) Trial Group: The effects of frequent nocturnal home hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80: 1080-1091, 2011
21. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M, and the Frequent Hemodialysis Network Trial Group: Solute clearances and fluid removal in the Frequent Hemodialysis Network trials. Am J Kidney Dis 53: 835-844, 2009
22. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. Covariance PatternModels, Philadelphia, John Wiley & Sons, 2004, pp 166-173